Veterinary Infusion Pumps Market Size & Growth Forecast 2026–2035, By Segments (Product Type, End-use, Animal Type, Route of Administration, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Veterinary Infusion Pumps Market size was more than USD 302.23 Million in 2025 and is set to grow at a 7.5% CAGR between 2026 and 2035, crossing USD 622.91 Million by 2035. The industry revenue for 2026 is estimated at USD 322.09 million.

• Base Year Value (2025): USD 302.23 Million
• CAGR (2026-2035): 7.5%
• Forecast Year Value (2035): USD 622.91 Million
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Veterinary Infusion Pumps Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America holds a 32.86% share due to advanced veterinary care, higher treatment spending, and widespread use of precise infusion systems in surgical and critical care settings.
  • Asia Pacific is expanding at an 8.48% CAGR, driven by modernization of veterinary services and increasing adoption of controlled drug-delivery systems in surgery and intensive care.

• Segment Momentum:

  • Volumetric infusion pumps accounted for 73.92% of the market in 2025 due to their versatility in routine fluid therapy, drug delivery, and longer-duration infusion procedures across multiple animal care settings.
  • Home care is the fastest-growing end-use segment as pet owners increasingly seek convenient treatment options that reduce facility visits while supporting ongoing infusion therapy outside clinical settings.

• Market Expansion Drivers:

  • Increasing veterinary surgeries and hospitalizations driving demand for precise drug delivery systems.
  • Rising adoption of advanced infusion technologies enabling accurate dosing and monitoring.
  • Expanding pet insurance coverage improving affordability of advanced veterinary treatments.

• Leading Market Participants:

  Top companies in the veterinary infusion pumps market include B. Braun Melsungen AG (Germany), Baxter International Inc. (United States), Fresenius Kabi AG (Germany), ICU Medical, Inc. (United States), Mindray Bio-Medical Electronics Co., Ltd. (China), Eitan Medical Ltd. (Israel), Heska Corporation (United States), Burtons Medical Equipment Ltd (United Kingdom), Digicare Biomedical Technology Inc. (United States), Avante Health Solutions (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 302.23 Million
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 622.91 Million by 2035
  • Growth Forecasts: 7.5% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Volumetric Infusion Pumps (Product Type) | Veterinary Hospitals & Clinics (End-use) | Companion Animals (Animal Type) | Intravenous (IV) (Route of Administration) | Fluid Therapy (Application)
  • Emerging Opportunity Segment: Syringe Infusion Pumps (Product Type) | Home Care (End-use) | Companion Animals (Animal Type) | Subcutaneous (Route of Administration) | Nutrition (Application)

Market Growth Drivers and Industry Trends

Increasing veterinary surgeries and hospitalizations increasing demand for precise drug delivery systems

As surgical volumes and inpatient care requirements rise, veterinary providers are relying more heavily on equipment that can deliver fluids, anesthetics, analgesics, and critical medications with consistent accuracy over extended treatment periods. In the veterinary infusion pumps market, this shift is closely tied to the operational demands of post-operative recovery, intensive monitoring, and emergency stabilization, where manual administration creates greater variability and staff burden. Hospitals and specialty clinics are investing in infusion systems because they support tighter control over dosing for animals of different sizes and physiological conditions, strengthening market development through routine use in procedures and longer hospitalization cases.

Rising adoption of advanced infusion technologies enabling accurate dosing and monitoring

The move toward smarter infusion platforms is influencing purchasing decisions by aligning drug delivery with the growing clinical sophistication of veterinary care. In the veterinary infusion pumps market, advanced technologies such as programmable settings, dose control features, and monitoring capabilities are gaining traction because they reduce administration errors and help clinicians manage complex treatment protocols more efficiently. This is increasing market penetration in multi-specialty hospitals and better-equipped clinics, where providers are prioritizing devices that improve workflow, support safer treatment delivery, and fit with a broader shift toward technology-enabled patient management.

Expanding pet insurance coverage improving affordability of advanced veterinary treatments

Broader pet insurance uptake is changing treatment economics by making owners more willing to approve procedures and inpatient therapies that involve higher clinical intensity and equipment use. For the veterinary infusion pumps market, that translates into stronger demand from practices offering advanced surgical care, critical care, and monitored recovery services, since reimbursement support reduces price sensitivity around treatment plans that depend on controlled infusion. As insured patients are more likely to receive comprehensive interventions rather than minimal care, providers gain stronger justification for maintaining and upgrading infusion pump capacity, contributing to market size growth through higher utilization of advanced veterinary treatment pathways.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Increasing veterinary surgeries and hospitalizations driving demand for precise drug delivery systems	2.00%	Moderate	North America, Europe	High	Near Term
Rising adoption of advanced infusion technologies enabling accurate dosing and monitoring	1.50%	Moderate	North America, Asia Pacific	High	Mid Term
Expanding pet insurance coverage improving affordability of advanced veterinary treatments	1.00%	Moderate	North America, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 32.86% share of the veterinary infusion pumps market in 2025, backed by broad access to advanced veterinary care, higher spending on companion animal treatment, and stronger uptake of precision drug-delivery equipment in clinics and hospitals. The region’s lead is reinforced by the routine use of infusion systems in surgical care, critical care, and long-duration fluid therapy, where reliability, dose accuracy, and workflow efficiency matter directly in day-to-day practice. A more established veterinary infrastructure also helps sustain replacement demand for upgraded pump systems and supports wider availability of trained professionals who can integrate these devices into regular treatment protocols.

Asia Pacific is projected to expand at an 8.48% CAGR over the forecast period, with growth in the veterinary infusion pumps market being impelled by the steady modernization of animal healthcare services and rising adoption of advanced treatment equipment across veterinary facilities. Demand is accelerating as clinics and hospitals increasingly move beyond basic fluid administration toward more controlled infusion delivery for surgery, hospitalization, and intensive care cases. The region’s momentum is also tied to the practical expansion of veterinary service capacity, which is bringing a larger base of animal care providers into the market for infusion technologies.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Nascent	Nascent
Cost-Sensitive Region	Low	Medium	Low	High	High
Regulatory Environment	Restrictive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Moderate	Strong	Weak	Weak
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	Medium	High	Low	Low
New Entrants / Startups	Dense	Moderate	Dense	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Weak	Weak

Key Country Insights

United States

Advanced Veterinary Care

The U.S. veterinary infusion pumps market is shaped by expanding specialty animal hospitals and greater adoption of precision fluid delivery systems. Veterinary providers prioritize programmable infusion technologies that improve treatment accuracy for companion animals and complex surgical procedures.

Japan

Precision Animal Treatment

Japan focuses on veterinary infusion pumps that enable accurate medication and fluid administration for aging companion animals and specialized veterinary care. Japanese veterinary facilities increasingly adopt compact, user-friendly systems that support advanced clinical procedures with dependable dosing control.

South Korea

Companion Care Expansion

South Korea strengthens adoption of veterinary infusion pumps as companion animal healthcare becomes increasingly sophisticated. Veterinary hospitals in South Korea prioritize integrated infusion technologies that improve patient monitoring and support efficient delivery of critical care treatments.

Germany

Clinical Equipment Modernization

Germany emphasizes modern veterinary infusion systems that support safe anesthesia, fluid therapy, and intensive care across companion and livestock practices. German clinics increasingly invest in reliable equipment with digital monitoring capabilities to enhance treatment consistency and workflow efficiency.

France

Veterinary Hospital Efficiency

France promotes veterinary infusion pump adoption through investments in advanced clinical equipment for animal hospitals and referral centers. French veterinary professionals emphasize dependable infusion management solutions that support surgical care, emergency medicine, and intensive treatment protocols.

Italy

Practice Technology Upgrade

Italy expands the use of veterinary infusion pumps as veterinary clinics modernize diagnostic and treatment capabilities. Italian providers increasingly seek durable infusion systems that improve procedural efficiency while supporting consistent therapeutic outcomes across companion animal care.

Segment Leadership and Growth Trends

  Product Type Segment Analysis: Volumetric Infusion Pumps (Largest Segment) vs Syringe Infusion Pumps (Fastest-Growing Segment)

Within the veterinary infusion pumps market, Volumetric Infusion Pumps held a 73.92% share in 2025, reflecting their established role in routine fluid therapy, drug delivery, and longer-duration infusion procedures across animal care settings. Their leadership is underpinned by broad clinical applicability, especially where caregivers need dependable delivery of larger fluid volumes across different species and treatment conditions. This practical versatility keeps Volumetric Infusion Pumps central to day-to-day veterinary workflows and supports their continued dominance in the product mix.

Syringe Infusion Pumps are emerging as the fastest-growing product type in the veterinary infusion pumps market because they better align with the need for highly controlled, low-volume infusion in critical care and precision medication use. Their growth momentum is reinforced through situations where dosing accuracy is especially important, including smaller animals and therapies requiring tighter infusion control than alternatives typically provide. As veterinary treatment becomes more tailored and monitoring-intensive, Syringe Infusion Pumps are experiencing stronger uptake faster than broader-volume systems.

End-use Segment Analysis: Veterinary Hospitals & Clinics (Largest Segment) vs Home Care (Fastest-Growing Segment)

Veterinary Hospitals & Clinics accounted for a 51.1% share of the veterinary infusion pumps market in 2025, making them the leading end-use segment. Their position is rooted in the concentration of infusion-dependent procedures in professional care environments, where trained staff, monitoring capability, and access to a wider range of treatment protocols support consistent pump utilization. The segment’s share remains strongest because infusion therapy often requires controlled administration and supervision that are more reliably available in clinical settings.

Home Care is the fastest-growing end-use segment in the veterinary infusion pumps market as animal care increasingly extends beyond traditional facilities into more flexible treatment settings. Growth is being driven by the practical appeal of managing selected infusion needs outside hospitals and clinics, particularly when ongoing care benefits from reduced facility visits and greater convenience for pet owners. Relative to institutional settings, Home Care is gaining momentum because it fits the shift toward longer-term management models where appropriate infusion support can be continued in a non-clinical environment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product Type	Volumetric Infusion Pumps, Syringe Infusion Pumps	Volumetric Infusion Pumps	Syringe Infusion Pumps
End-use	Veterinary Hospitals & Clinics, Home Care, Research & Academic Institutions, Others	Veterinary Hospitals & Clinics	Home Care
Animal Type	Companion Animals, Livestock Animals	Companion Animals	Companion Animals
Route of Administration	Intravenous (IV), Subcutaneous, Epidural Infusion, Others	Intravenous (IV)	Subcutaneous
Application	Fluid Therapy, Anesthesia, Pain Management, Nutrition, Others	Fluid Therapy	Nutrition

Competitive Landscape and Market Positioning

Leading companies in the veterinary infusion pumps market:

1. B. Braun Melsungen AG (Germany)

2. Baxter International Inc. (United States)

3. Fresenius Kabi AG (Germany)

4. ICU Medical Inc. (United States)

5. Mindray Bio-Medical Electronics Co. Ltd. (China)

6. Eitan Medical Ltd. (Israel)

7. Heska Corporation (United States)

8. Burtons Medical Equipment Ltd (United Kingdom)

9. Digicare Biomedical Technology Inc. (United States)

10. Avante Health Solutions (United States)

The veterinary infusion pumps market is witnessing strong competitive momentum as manufacturers focus on developing advanced infusion systems capable of delivering accurate fluid management across varied animal care settings. Enhanced touchscreen controls, programmable dosing features, and portable configurations are becoming key differentiation areas within the veterinary infusion pumps market. Continuous product upgrades and technological refinement are helping suppliers address growing expectations for safety, precision, and ease of use in veterinary treatment procedures.

Industry Development/News

Company Name	Date	Key Development
Patterson Companies, Inc.	Oct-24	Patterson Companies Inc. expanded its veterinary portfolio by signing a definitive agreement to acquire UK-based Infusion Concepts Ltd. through its subsidiary National Veterinary Services Limited. The strategic transaction integrates a specialized line of veterinary infusion pumps, drainage, and critical care products into Patterson's international medical supply chain.
Mars Incorporated	Jun-23	Mars Incorporated completed the corporate acquisition of HESKA Corporation, a developer of specialized veterinary diagnostics and critical care solutions. This milestone transaction absorbs HESKA's dedicated veterinary infusion pump lines into Mars Petcare’s science and diagnostics division, rapidly scaling its clinical hardware market share.